Gene Solutions Leads the Way in Cancer Early Detection with Asia's First Clinical Validated Multi-Cancer Blood Test
SINGAPORE, March 26, 2025 /PRNewswire/ -- Gene Solutions, a leading biotech company in Asia, proudly announces a groundbreaking achievement in cancer early detection. The company's innovative SPOT-MAS test has become the first multi-cancer screening...
Lithium Africa Resources Corp. Announces $6M Equity Financing and Intention to Complete a Listing on a Canadian Stock Exchange
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES LISBON, Portugal, Feb. 10, 2025 /PRNewswire/ -- Lithium Africa Resources Corp. ("Lithium Africa" or the "Company") is pleased to announce that...
Sungrow and CEEC Complete Central Asia's Largest Energy Storage Project
TASHKENT, Uzbekistan, Jan. 24, 2025 /PRNewswire/ -- Sungrow, the global leading PV inverter and energy storage system (ESS) provider, in partnership with China Energy Engineering Corporation (CEEC), are proud to announce the successful commissioning...
Hanwha and Baker Hughes Enter into Joint Development Agreement for Ammonia Gas Turbines
Hanwha Power Systems and Hanwha Ocean cooperate with global energy technology company Baker Hughes. Leading the decarbonization of the hard-to-abate marine transportation sector through fuel-flexible combustion technology. SEOUL, South Korea, Feb....
Next Level Aviation® Commences Recap of Turning Rock Partners
NLA to complete the full redemption of Turning Rock's preferred equity investment by June 30, 2025 DANIA BEACH, Fla., Jan. 14, 2025 /PRNewswire/ -- Next Level Aviation® (NLA), a leader in the global distribution of used serviceable materials (USM)...
Huawei and Moroccan Government Boost National Education Transformation through DigiSchool Project
AGADIR, Morocco, Dec. 30, 2024 /PRNewswire/ -- Huawei has announced the successful completion of the DigiSchool 2024 project in Morocco, highlighting its contribution to ensuring equitable access to digital technology for all students in the...
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Announce Successful Completion of a First-in-Human Study for Potential Disease-Modifying Therapy for Parkinson's Disease
HL192 (ATH-399A) was well tolerated with no major safety issues in any of the 76 participants. No serious treatment related adverse events were reported and such findings were proportional between placebo and dosed groups. PK results support once a...
Continuously optimize user experience, Baijiayun's live and on-demand products complete autumn upgrade
BEIJING, Nov. 22, 2024 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, recently announced it has completed autumn upgrade. Driven by both technological development and market...
